Stem Cell Renewalmaintenance And Tissue Regeneration Are Critical For Normal Health And Well Beingwnt Pathway Interactions Are Crucial To Maintenance Of These Processesankasa Is The First To Produce Human Wnt Proteins In A Manufacturing Setting Suitable For Use In Humansleading To Clinical Candidate Art352 L Successful Development Of Art352 L Will Enhance The Osteogenic Properties Of Patient Derived Stem Cells Used In Reconstructive Surgeries And Provide Safe And Effective Enhancement Of Bone Formation In Indications For Which This Is A Significant Unmet Medical Need
No conferences found for this company.
| Company Name | Ankasa Regenerative Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
